Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The procedure entails thorough molecular simulations of the catalytic and allosteric binding pockets, accompanied by ensemble virtual screening that factors in their conformational flexibility. When developing modulators, the structural modifications brought about by reaction intermediates are factored in to optimize activity and selectivity.
Key features that set our library apart include:
partner
Reaxense
upacc
Q96MA6
UPID:
KAD8_HUMAN
Alternative names:
ATP-AMP transphosphorylase 8
Alternative UPACC:
Q96MA6; A8K821; Q8N9W9
Background:
Adenylate kinase 8, also known as ATP-AMP transphosphorylase 8, plays a crucial role in cellular energy homeostasis. It catalyzes the reversible transfer of phosphate groups between nucleoside triphosphates and monophosphates, with a preference for AMP. This enzyme exhibits broad nucleoside diphosphate kinase activity, impacting various cellular processes.
Therapeutic significance:
Understanding the role of Adenylate kinase 8 could open doors to potential therapeutic strategies. Its involvement in nucleotide metabolism positions it as a key player in cellular energy balance, suggesting its potential in targeting metabolic disorders.